Technical Study of TRVI which had gain of over 500%

NASDAQ:TRVI   Trevi Therapeutics, Inc.
TRVI had over 500% gain since it uptrend started in Feb-2022. I have made a study on potential entry and exit points illustrated in the chart.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.